FDA, CDC Urge Halting Of Johnson & Johnson Vaccine Over ‘Extremely Rare’ Blood Clotting, by Jordan Davidson

By Jordan Davidson, The Federalist, April 13, 2021

Jordan Davidson is a staff writer at The Federalist. She graduated from Baylor University where she majored in political science and minored in journalism.

The Food and Drug Administration along with the Centers for Disease Control and Prevention are urging COVID-19 vaccination sites to cease administering doses of the Johnson & Johnson vaccine after a minimum of six women in the United States suffered from a type of blood clotting that, in at least one case, was fatal.

The women who suffered this specific blood clotting, all between the ages of 18 and 48, saw symptoms after six to 13 days post-inoculation. While clotting is generally treated by anticoagulant drugs such as heparin, the federal agencies warned that for this particular type of coagulation, “administration of heparin may be dangerous, and alternative treatments need to be given.” ….

Continue reading >>>>